Valuation: Realcan Pharmaceutical Group Co., Ltd.

Market Cap 4.75B 708M 632M 590M 536M 1.01B 68.58B 1.02B 7.08B 2.77B 34.85B 2.66B 2.6B 112B P/E 2024
217x
P/E 2025 322x
Enterprise Value 5.61B 836M 747M 697M 633M 1.19B 81B 1.2B 8.37B 3.27B 41.16B 3.14B 3.07B 132B EV / Sales 2024
0.76x
EV / Sales 2025 0.77x
Free-Float
69.3%
Yield 2024
0.37%
Yield 2025 0.06%
1 day-1.22%
1 week-1.22%
Current month-1.22%
1 month-3.87%
3 months+24.71%
6 months-5.56%
Current year+0.31%
1 week 3.19
Extreme 3.19
3.38
1 month 2.9
Extreme 2.9
3.95
Current year 2.38
Extreme 2.38
4.11
1 year 2.38
Extreme 2.38
4.69
3 years 2.05
Extreme 2.05
4.69
5 years 2.05
Extreme 2.05
6.73
10 years 2.05
Extreme 2.05
18.26
Manager TitleAgeSince
Director of Finance/CFO 56 2021-04-25
President 61 2023-05-25
Corporate Officer/Principal 40 2019-10-29
Director TitleAgeSince
Chairman 61 2009-11-20
Director/Board Member 43 2009-11-20
Chairman 48 2019-10-07
Date Insider Type Main position Quantity % Market Cap. Importance
5/12/23 Sell

Founder

15,000,000 1.2902%
3/30/23 Sell

Founder

13,040,000 1.1260%
3/30/23 Sell

Chairman

2,000,000 0.1727%
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%-1.22% - - 717M
Average -1.22%
Weighted average by Cap. -1.22%

Financials

2024 2025
Net sales 7.97B 1.19B 1.06B 990M 899M 1.69B 115B 1.71B 11.88B 4.65B 58.46B 4.46B 4.36B 188B 7.3B 1.09B 972M 906M 823M 1.55B 105B 1.56B 10.88B 4.26B 53.54B 4.08B 4B 172B
Net income 20.62M 3.08M 2.75M 2.56M 2.33M 4.38M 298M 4.42M 30.76M 12.03M 151M 11.55M 11.29M 487M 16.07M 2.4M 2.14M 2M 1.81M 3.41M 232M 3.45M 23.97M 9.38M 118M 9M 8.8M 379M
Net Debt 1.6B 238M 212M 198M 180M 339M 23.04B 342M 2.38B 931M 11.71B 893M 874M 37.65B 860M 128M 115M 107M 97.08M 183M 12.42B 184M 1.28B 502M 6.31B 482M 471M 20.3B
Projected Income Statement - Annual - Realcan Pharmaceutical Group Co., Ltd.
Logo Realcan Pharmaceutical Group Co., Ltd.
Realcan Pharmaceutical Group Co Ltd, formerly Realcan Pharmaceutical Co Ltd, is a China-based company mainly engaged in the provision of comprehensive medical service. The Company operates five businesses. The drug and device distribution business is mainly responsible for drug and device distribution services and comprehensive medical services. The in vitro diagnostic business covers all fields such as laboratory biochemistry, immunity, and clinical examination. The digital health business provides one-stop health management solutions. The pharmaceutical logistics business provides pharmaceutical and medical device logistics services. The traditional Chinese medicine business is engaged in the research, development and production of traditional Chinese medicine pieces, granules, new traditional Chinese medicines, liquefied traditional Chinese medicine products, and health foods. The Company mainly operates in the domestic market, with Shandong as its main market.
Employees
2,407
Date Price Change Volume
26-10-08 CN¥3.230 -1.22% 74,304,411
26-09-30 CN¥3.270 +0.93% 98,842,535
  1. Stock Market
  2. Stocks
  3. 002589 Stock